Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9437 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9388 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.9353 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9353 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9286 |
High Similarity |
NPD1549 |
Phase 2 |
0.9189 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9071 |
High Similarity |
NPD1510 |
Phase 2 |
0.906 |
High Similarity |
NPD7819 |
Suspended |
0.9054 |
High Similarity |
NPD7411 |
Suspended |
0.9034 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9007 |
High Similarity |
NPD7075 |
Discontinued |
0.9007 |
High Similarity |
NPD2796 |
Approved |
0.8986 |
High Similarity |
NPD4380 |
Phase 2 |
0.8933 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8921 |
High Similarity |
NPD1240 |
Approved |
0.8867 |
High Similarity |
NPD1934 |
Approved |
0.8794 |
High Similarity |
NPD1607 |
Approved |
0.8782 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.871 |
High Similarity |
NPD6959 |
Discontinued |
0.8693 |
High Similarity |
NPD7768 |
Phase 2 |
0.8636 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8618 |
High Similarity |
NPD6801 |
Discontinued |
0.8581 |
High Similarity |
NPD1511 |
Approved |
0.8581 |
High Similarity |
NPD6799 |
Approved |
0.8562 |
High Similarity |
NPD2800 |
Approved |
0.8562 |
High Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD2801 |
Approved |
0.8526 |
High Similarity |
NPD5494 |
Approved |
0.8511 |
High Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8503 |
High Similarity |
NPD3750 |
Approved |
0.85 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8493 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8487 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8467 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8452 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8428 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8428 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8428 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8414 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8405 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.8403 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8397 |
Intermediate Similarity |
NPD3749 |
Approved |
0.838 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8369 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8356 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8278 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8278 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8278 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8269 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8261 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8261 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8231 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8231 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8231 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8221 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8188 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8187 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8176 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8171 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.817 |
Intermediate Similarity |
NPD920 |
Approved |
0.8163 |
Intermediate Similarity |
NPD3748 |
Approved |
0.816 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8146 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.811 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8101 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8061 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8052 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8049 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.8049 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8041 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8039 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8023 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.8023 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.8013 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8013 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7972 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7964 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7961 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7949 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7933 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7922 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7902 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7902 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7874 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7874 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7862 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7848 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7842 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7838 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7838 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7808 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7806 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.78 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD919 |
Approved |
0.777 |
Intermediate Similarity |
NPD943 |
Approved |
0.7744 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7744 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7722 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7722 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7692 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7683 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7655 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7655 |
Intermediate Similarity |
NPD3267 |
Approved |
0.764 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7639 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7636 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7635 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7598 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7582 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7569 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7566 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7551 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7548 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7533 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7533 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7528 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1201 |
Approved |
0.75 |
Intermediate Similarity |
NPD8312 |
Approved |
0.75 |
Intermediate Similarity |
NPD8313 |
Approved |
0.75 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7484 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD17 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7466 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7465 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7432 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7415 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7415 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7407 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7407 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7403 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7403 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7403 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7403 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7403 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7403 |
Intermediate Similarity |
NPD5406 |
Approved |
0.74 |
Intermediate Similarity |
NPD3764 |
Approved |
0.74 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7384 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7368 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7362 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7357 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7355 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7355 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7355 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7355 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7353 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7347 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7337 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7324 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7321 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7317 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7317 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7317 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7308 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7296 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD411 |
Approved |
0.7273 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD37 |
Approved |
0.7256 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7256 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7255 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7251 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7248 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7239
|
Intermediate Similarity |
NPD6585 |
Discontinued |